Bartels GL, Remme WJ, den Hartog FR, et al
Phase 2 Trials The findings of phase 1 studies supported the continued clinical development of retatrutide as a promising candidate for the treatment of obesity and T2D
The first-month guide explains the bigger checklist: dose timing, injection site or pill routine, food tolerance, protein, fiber, water, side effects, bowel changes, weight trend, progress photos, movement, sleep, energy, and anything you may want to remember if you talk with a clinician
No dose adjustment is required for mild or moderate kidney impairment, though severe impairment lacks adequate study data
10.1038/nature07422 29 KillionE
Why does semaglutide cause hair loss